Insider Trading June 15, 2026 07:43 PM

Lam Research Director Eric Brandt Executes $20.01 Million Share Sale Under Pre-Arranged Plan

Executive transaction occurs amid analyst upgrades and broader semiconductor equipment sector volatility linked to U.S. export controls.

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
LRCX

Lam Research Corp (NASDAQ:LRCX) director Eric Brandt executed a significant divestment of company equity on June 12, 2026, selling 54,500 shares for a total value of $20,011,345. The transaction was facilitated through a Rule 10b5-1 trading plan established earlier in the year. This sale reduces Brandt’s direct holdings, which include unvested restricted stock units, to 144,705 shares. The transaction takes place as Lam Research shares trade near their 52-week high of $393.07, following a substantial 338% gain over the past year. Concurrently, the semiconductor equipment sector is navigating a complex landscape of analyst optimism and regulatory constraints.

Lam Research Director Eric Brandt Executes $20.01 Million Share Sale Under Pre-Arranged Plan
LRCX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Lam Research director Eric Brandt sold 54,500 shares for $20,011,345 under a pre-arranged Rule 10b5-1 plan, reducing his direct holdings to 144,705 shares.
  • Analysts have revised forecasts positively, with Morgan Stanley, Cantor Fitzgerald, and Mizuho raising price targets based on NAND growth and AI-driven advanced packaging.
  • The semiconductor equipment sector faces regulatory headwinds from U.S. Department of Commerce restrictions on shipments to China's Hua Hong, impacting multiple companies.

Eric Brandt, serving as a director at Lam Research Corp (NASDAQ:LRCX), executed a substantial divestment of company equity on June 12, 2026. The transaction involved the sale of 54,500 shares of the company's common stock, generating a total value of $20,011,345. The execution of these sales occurred within a price range of $355.71 to $373.09 per share. This activity reduces Brandt's direct equity position in the semiconductor equipment manufacturer. Following the completion of these sales, Brandt holds 144,705 shares of Lam Research common stock. This reported figure encompasses shares subject to unvested restricted stock units.

The transaction was conducted pursuant to a Rule 10b5-1 trading plan. This pre-arranged framework was adopted by Mr. Brandt on February 6, 2026, establishing the parameters for the divestment activity. The use of such a plan typically indicates that the sales were scheduled in advance rather than driven by immediate market timing decisions.

The sale occurs against a backdrop of significant price appreciation for Lam Research equity. The stock has climbed to $388.92, trading near its 52-week high of $393.07. This current valuation reflects a remarkable 338% gain over the past year. According to InvestingPro analysis, the stock appears overvalued at current levels, with shares trading at a P/E ratio of 73.56. The equity closed at 388.92, up 22.11 or 6.03%, following a session that saw activity in the after-hours market at 387.00, down 1.92 or 0.49%.

Concurrently, Lam Research has been the focus of several analyst upgrades and revised forecasts. Morgan Stanley upgraded its rating on Lam Research to Overweight from Equalweight, raising the price target to $331, citing a strong outlook for NAND systems growth. Cantor Fitzgerald also increased its price target for Lam Research to $425, highlighting AI-driven advanced packaging as a key growth driver. Similarly, Mizuho raised its price target to $380, reflecting an optimistic wafer fab equipment outlook for the coming years.

In corporate financial news, Lam Research’s Board of Directors declared a quarterly dividend of $0.26 per share. This distribution is payable on July 8, 2026, to shareholders of record as of June 17, 2026. This dividend declaration provides income to equity holders while the company navigates a complex operational environment.

Broader sector dynamics are also influencing Lam Research operations. A report indicates that the U.S. Department of Commerce has imposed restrictions on shipments to China’s Hua Hong. This development has impacted several chip equipment stocks, including Lam Research. The restrictions follow letters reportedly sent to companies informing them of new rules on tools destined for Hua Hong facilities. These regulatory constraints introduce operational challenges for semiconductor equipment manufacturers operating in the global market.

Lam Research continues to be analyzed for investment strategies, with platforms evaluating LRCX alongside thousands of other companies using financial metrics. The company's stock performance and analyst sentiment reflect the broader semiconductor equipment sector's volatility and growth potential.

Risks

  • Valuation concerns persist as Lam Research trades at a P/E ratio of 73.56, with analysis suggesting the stock appears overvalued at current levels.
  • Regulatory restrictions from the U.S. Department of Commerce on shipments to China's Hua Hong introduce uncertainty for semiconductor equipment manufacturers.
  • Market volatility is evident in after-hours trading, with LRCX down 0.49% post-close, reflecting broader sector fluctuations.

More from Insider Trading

Chegg CEO Daniel Rosensweig's Shares Withheld for Tax Obligations Jun 15, 2026 Mobix Labs President and CFO Samini Offloads Shares Amid Strategic Expansion Jun 15, 2026 Corvel CEO Offloads 500 Shares Amid Undervaluation Signals and Q4 Growth Jun 15, 2026 Fold Holdings Insider Purchase Highlights Director Confidence Amid Operational Headwinds Jun 15, 2026 Tigo Energy Director Sagit Manor Offloads $180,975 in Shares Following RSU Vesting Jun 15, 2026